Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy

Rishi Deka; Daniel R Simpson; Alex K Bryant; Vinit Nalawade; Rana McKay; J D Murphy; Brent S Rose

doi:10.1001/jamaoncol.2018.4423

Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy

JAMA Oncol. 2018 Nov 1;4(11):1616-1617. doi: 10.1001/jamaoncol.2018.4423.

Authors

Rishi Deka^{1

2

3}, Daniel R Simpson^{1

2

3}, Alex K Bryant^{1

2}, Vinit Nalawade^{1

2

3}, Rana McKay^{1

2}, J D Murphy^{1

2

3}, Brent S Rose^{1

2

3}

Affiliations

¹ Veterans Affairs San Diego Health Care System, La Jolla, California.
² Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla.
³ University of California San Diego Center for Precision Radiation Medicine, La Jolla.

Abstract

This cohort study examines the association of androgen deprivation therapy with dementia in male veterans with prostate cancer who receive definitive radiotherapy.

MeSH terms

Androgen Antagonists / adverse effects
Androgen Antagonists / pharmacology
Cohort Studies
Dementia / chemically induced*
Humans
Male
Prostatic Neoplasms / complications*
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / radiotherapy

Substances

Androgen Antagonists